Resveratrol has been shown to reverse some of the detrimental effects of metabolic syndrome (MetS).
Additionally, anti-IL-1β blocking antibodies have been shown to reverse lung pathology in steroid-resistant models of severe asthma53.
Ventricular support devices have been shown to reverse pathological ventricular remodeling, improve systolic function, and improve symptoms of heart failure.
As well as aiding weight loss, the procedure has been shown to reverse cases of type 2 diabetes within 48 hours by changing levels of gut hormones.
Inhibiting protein phosphatase-1 through the overexpression of a constitutively active inhibitor-1 (I-1c) has been shown to reverse cardiac dysfunction in a model of ischemic HF.
Supplementing the body's dwindling supply with recombinant human growth hormone (rHGH) has been shown to reverse the signs and symptoms of aging.
Dopamine D1 agonists have been shown to reverse performance deficits in both aged non-human primates and in primates with lesions to dopamine systems.
Meanwhile unloading (resting) the deteriorating LV has been shown to reverse many cellular and molecular changes in heart failure promoting improvement in myocardial function.
Although gene therapy-mediated transdetermination of hepatic oval cells to authentic-looking and functioning β cells has been shown to reverse diabetes in mice, vector toxicity has precluded application of the technology in clinical trials.
Weight loss of at least 5% has been shown to reverse obesity-related anovulation.
Currently there is no treatment that has been shown to reverse the anticoagulant effect of the drug.
